UnitedHealth Group Incorporated (UNH)[Tv]

Key Developments

• Berkshire Hathaway completed its full exit from UnitedHealth Group (UNH) stake in Q1 2026, marking a definitive break from a long-standing institutional relationship and triggering widespread market skepticism despite UNH’s strong fundamentals—a seismic shift signaling a loss of confidence in the company’s long-term regulatory sustainability.

• UNH launched a transformative, full-scale transition to a transparent, flat-service fee model at Optum Rx by 2027, a first-in-industry move designed to rebuild trust in pharmacy benefit management, align stakeholder incentives, and establish a new benchmark for transparency in healthcare costs.

• Massachusetts Attorney General filed a lawsuit alleging systemic upcoding in UNH’s Medicaid programs, claiming over $100 million in unjustified payments through inflated patient severity scores—posing a material reputational and financial risk with potential ripple effects across state-level managed care operations.

• UNH raised its 2026 adjusted EPS guidance to over $18.25 and confirmed a 90-basis-point improvement in its medical care ratio, delivering a Q1 earnings beat and reinforcing ongoing operational recovery, margin expansion, and disciplined cost management.